Related Experiment Video
Updated: Jun 28, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
The pathway to dementia diagnosis
Catherine M Speechly1, Charles Bridges-Webb, Erin Passmore
1Projects, Research and Development Unit, NSW and ACT Faculty, Royal Australian College of General Practitioners, Sydney, NSW.
Objective:
To describe the steps taken by health professionals to diagnose dementia and the timeframes for these steps, as reported by carers.
Design, Setting And Participants:
A cross-sectional, anonymous survey was mailed or distributed by Alzheimer's Australia New South Wales, six Sydney residential aged care facilities and 13 Sydney general practitioners to 415 carers or family members of patients with dementia between May and August 2007.
Main Outcome Measures:
First symptoms noticed and actions taken; time to first health professional consultation and diagnosis; reported actions of first health professional; satisfaction with first consultation; and use of dementia and chronic illness resources.
Results:
209 surveys were returned. Family members noticed the first symptoms of dementia at a mean of 1.9 years before the first health professional consultation about dementia, and 3.1 years before a firm diagnosis. Resource use first occurred 2.8 years after the first symptoms. Most carers (72%) were satisfied with the first consultation, which was usually with a GP (84%). Two-thirds of carers (64%) reported that the first health professional had performed a memory test.
Conclusions:
Delays in presentation, diagnosis and resource use may have clinical and social implications for people with dementia and their families, in addition to the challenges of the process of obtaining a firm diagnosis.
Related Concept Videos
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Parkinson Disease ll: Pathophysiology
